Status:
RECRUITING
Digital Phenotyping for Changes in Activity at the End of Life in People With Dementia
Lead Sponsor:
University of Bergen
Collaborating Sponsors:
Helse Vest
Haukeland University Hospital
Conditions:
Dementia
Eligibility:
All Genders
65+ years
Brief Summary
Background: Almost 90% of people with dementia develop serious symptoms such as apathy, agitation, pain, and sleep disturbances. Movement and participation in daily activities also decrease dramatica...
Detailed Description
About 90% of people with dementia develop behavioral and psychological symptoms such as agitation, depression and psychosis. In addition, their activity levels decrease over time. Traditional outcome ...
Eligibility Criteria
Inclusion
- People with dementia or who have a likely diagnosis of dementia
- Hospital (admitted for \>3 days)
- Nursing home resident
- \>64 years old
- Score of \<4 on the 4 A's Test for Delirium (4AT) will be required for inclusion (no delirium)
Exclusion
- People without dementia or cognitive impairment
- People that are considered already in a health status emergency (\< 6 weeks to live)
- People that are not living in the nursing home
Key Trial Info
Start Date :
May 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06032091
Start Date
May 2 2023
End Date
May 1 2026
Last Update
May 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bergen Røde Kors Sykehjem AS
Bergen, Vestland, Norway, 5043